E09.42 ICD-10-CM Code: Drug or chemical induced diabetes mellitus with neurological complications with diabetic polyneuropathy
E09.42 is not a CMS-HCC payment code. MEAT criteria · RAF Calculator · HCC coding software
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Endocrine, nutritional and metabolic diseases (E00-E89) / Diabetes mellitus (E08-E13)
E09.42
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceDrug or chemical induced diabetes mellitus with neurological complications with diabetic polyneuropathy
Diabetes caused by medications or chemicals that damages multiple nerves throughout the body, typically causing numbness and weakness in the hands and feet.

Buddy Insight
Drug or chemical induced diabetes mellitus with diabetic polyneuropathy is the most common neuropathic complication of drug-induced diabetes, involving symmetric damage to multiple peripheral nerves.
CMS-HCC V28
N/A—
Not mapped
CMS-HCC V24
HistoricalHistorical
Not used for CY2026 payment
ACA/HHS
MappedHCC 020
Code-level coefficient reference
ESRD/PACE
MappedHCC 18
Code-level coefficient reference
RXHCC
MappedHCC 30
Code-level coefficient reference
Code Book Path
Inclusion Terms
Official- Drug or chemical induced diabetes mellitus with diabetic neuralgia
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for E09.42 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for E09.42 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for E09.42 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for E09.42 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for E09.42 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for E09.42 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is E09.42 an HCC code?
E09.42 is not in the CMS-HCC V28 or V24 community payment model. E09.42 has a separate mapping under the CMS-HCC ESRD model (HCC 18 (Diabetes with Chronic Complications)) and the Part D RxHCC model (HCC 30 (Diabetes with Complications)); the applicable result needs member context. E09.42 also appears in the HHS-HCC commercial risk model (HCC 020 (HHS-HCC 020 adult, RAF varies by metal level)), which is a commercial market model rather than a Medicare Advantage payment mapping.
- Code
- E09.42
- Description
- Drug or chemical induced diabetes mellitus with neurological complications with diabetic polyneuropathy
- HCC (V28)
- No CMS-HCC V28 mapping
- RAF reference coefficient
- —
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.
Work E09.42 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →
MEAT Criteria for E09.42
For E09.42 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed E09.42 during that encounter, not just copy-forwarded from a problem list.
Coder workflow notes
Get the V28 mapping + MEAT cheat sheet
One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
E09.42 is the ICD-10-CM diagnosis code for drug or chemical induced diabetes mellitus with neurological complications with diabetic polyneuropathy. Diabetes caused by medications or chemicals that damages multiple nerves throughout the body, typically causing numbness and weakness in the hands and feet. E09.42 sits in the ICD-10-CM chapter for endocrine, nutritional and metabolic diseases (e00-e89), within the section covering diabetes mellitus (e08-e13).
E09.42 has no mapping under the CMS-HCC V28 or V24 community payment models. E09.42 has a separate mapping under the CMS-HCC ESRD model (HCC 18 (Diabetes with Chronic Complications)) and the Part D RxHCC model (HCC 30 (Diabetes with Complications)); the applicable result needs member context. E09.42 also appears in the HHS-HCC commercial risk model (HCC 020 (HHS-HCC 020 adult, RAF varies by metal level)), which is a commercial market model rather than a Medicare Advantage payment mapping. Do not assign V28 risk adjustment value from this page; verify the applicable model and payment year before using this code for risk adjustment.
Document which nerves are affected and the distribution pattern (distal, symmetrical, etc.).
HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for E09.42 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Document which nerves are affected and the distribution pattern (distal, symmetrical, etc.)
- •Distinguish from mononeuropathy (E09.41) which affects only one nerve
Clinical Significance
Drug or chemical induced diabetes mellitus with diabetic polyneuropathy is the most common neuropathic complication of drug-induced diabetes, involving symmetric damage to multiple peripheral nerves. It typically presents with distal sensory loss in a 'stocking-glove' distribution, progressing from the feet proximally. Loss of protective sensation significantly increases risk for foot ulcers, infections, and amputations, making this a high-impact complication requiring proactive foot care and pain management.
Documentation Requirements
- ✓The causative drug or chemical must be documented and coded.
- ✓Clinical findings should describe the distribution pattern (distal, symmetric), affected modalities (sensory, motor, or both), and severity.
- ✓Monofilament testing results and vibration perception should be documented.
- ✓Nerve conduction studies, if performed, provide objective confirmation.
Commonly Confused Codes
- •E09.41 (mononeuropathy) affects a single nerve rather than multiple nerves.
- •E09.43 (autonomic neuropathy) affects involuntary nervous system functions.
- •E09.40 (unspecified neuropathy) should not be used when polyneuropathy is documented.
- •G63 (polyneuropathy in diseases classified elsewhere) should not replace the combination code.

